Asthma and allergic inflammation modulators

Details for Australian Patent Application No. 2003297398 (hide)

Owner Amgen Inc.

Inventors Wang, Yingcai; Xu, Qingge; Liu, Jiwen; Schmitt, Michael J.; Huang, Xi Alan; Medina, Julio C.; Fu, Zice; Tang, Lucy H.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003297398

PCT Number PCT/US2003/0406

PCT Pub. Number WO2004/058164

Priority 60/435,366 20.12.02 US

Filing date 19 December 2003

Wipo publication date 22 July 2004

Acceptance publication date 24 September 2009

International Classifications

C07C 205/37 (2006.01) Compounds containing nitro groups bound to a carbon skeleton

A61K 31/18 (2006.01) - Sulfonamides

C07C 205/56 (2006.01) Compounds containing nitro groups bound to a carbon skeleton

C07C 233/75 (2006.01) Carboxylic acid amides

C07C 271/28 (2006.01) Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups

C07C 275/42 (2006.01) Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups

C07C 311/08 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07C 311/21 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07C 311/29 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07D 209/22 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/26 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 213/71 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 215/36 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 233/84 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 243/12 (2006.01) Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms

C07D 243/24 (2006.01) Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms

C07D 257/04 (2006.01) Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

C07D 295/192 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 307/91 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 333/34 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 333/62 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

Event Publications

6 May 2004 Complete Application Filed

  Priority application(s): 60/435,366 20.12.02 US

26 August 2004 Application Open to Public Inspection

  Published as AU-B-2003297398

4 August 2005 Change of Name(s) of Applicant(s), Section 104

  Tularik, Inc. The name of the applicant has been changed to Amgen, Inc. 2004

20 August 2009 Alteration of Name

  The name of the applicant has been altered to Amgen Inc. 2004

24 September 2009 Application Accepted

  Published as AU-B-2003297398

21 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003297399-NUCLEIC ACIDS ENCODING ANTIFUNGAL DRUG TARGETS AND METHODS OF USE

2003297397-METHODS AND COMPOSITIONS FOR THE TREATMENT OF HERPES VIRUS INFECTIONS USING CYCLOOXYGENASE-2 SELECTIVE INHIBITORS OR CYCLOOXYGENASE-2 INHIBITORS IN COMBINATION WITH ANTIVIRAL AGENTS